Recardio

Regenerative Cardiac

  • About Us
    • Profile
    • Management
    • Boards
    • Awards
  • Science
    • Background
    • Rationale
    • Therapy
  • Clinical
    • Phase 1
    • Phase 2B AMI
    • Phase 2B CHF
  • News Center

Jun 21 2017

Recardio appoints Scientific Advisory Board

San Francisco, June 21st, 2017 – Recardio Inc. today announced that it has appointed its newly formed Scientific Advisory Board, reflecting the company’s entering the clinical phase 2 development in 2017.

Read More

Written by Recardio · Categorized: Uncategorized

Mar 27 2017

Recardio receives FDA Clearance

San Francisco, March 27th, 2017 – Recardio Inc. Receives FDA Clearance of IND in Regenerative Therapy Program. 

Read More

Written by Recardio · Categorized: Uncategorized

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • Contact us
  • Imprint
  • Data Privacy

© Recardio inc. 2021 · All Rights Reserved

Copyright © 2021 · Recardio on Genesis Framework · WordPress · Log in